NCT04102852View on ClinicalTrials.gov

Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Ulcerative Colitis Chronic MildUlcerative Colitis Chronic Moderate
Interventions
DIETARY_SUPPLEMENT

Lactobacillus rhamnosus GG ATCC 53103

probiotic administration at two different doses for 1 month

Trial Locations (1)

00184

S. Giovanni Addolorata Hospital, Roma

All Listed Sponsors
collaborator

Onlus S. Andrea

UNKNOWN

lead

San Giovanni Addolorata Hospital

OTHER

NCT04102852 - Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients | Biotech Hunter | Biotech Hunter